Assessment of the gut bacterial microbiome and metabolome of girls and women with Rett Syndrome.
Adolescent
Adult
Child
Child, Preschool
Feces
/ chemistry
Female
Gas Chromatography-Mass Spectrometry
Gastrointestinal Diseases
/ etiology
Gastrointestinal Microbiome
/ genetics
Humans
Metabolome
Phenotype
RNA, Ribosomal, 16S
/ genetics
Rett Syndrome
/ complications
Sequence Analysis, DNA
Severity of Illness Index
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
01
2021
accepted:
22
04
2021
entrez:
6
5
2021
pubmed:
7
5
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Gastrointestinal problems affect the health and quality of life of individuals with Rett syndrome (RTT) and pose a medical hardship for their caregivers. We hypothesized that the variability in the RTT phenotype contributes to the dysbiosis of the gut microbiome and metabolome in RTT, predisposing these individuals to gastrointestinal dysfunction. We characterized the gut bacterial microbiome and metabolome in girls and young women with RTT (n = 44) and unaffected controls (n = 21), and examined the relation between the composition of the microbiome and variations in the RTT phenotype. Demographics and clinical information, including growth and anthropometric measurements, pubertal status, symptoms, clinical severity score, bowel movement, medication use, and dietary intakes were collected from the participants. Fecal samples were collected for analysis of the gut microbiome using Illumina MiSeq-based next-generation sequencing of the 16S rRNA gene followed by bioinformatics analysis of microbial composition, diversity, and community structure. Selected end-products of microbial protein metabolism were characterized by liquid chromatography-mass spectrometry. The gut bacterial microbiome differed within the RTT cohort based on pubertal status (p<0.02) and clinical severity scores (p<0.02) of the individuals and the type of diet (p<0.01) consumed. Although the composition of the gut microbiome did not differ between RTT and unaffected individuals, concentrations of protein end-products of the gut bacterial metabolome, including γ-aminobutyric acid (GABA) (p<0.001), tyrosine (p<0.02), and glutamate (p<0.06), were lower in the RTT cohort. Differences in the microbiome within RTT groups, based on symptomatic anxiety, hyperventilation, abdominal distention, or changes in stool frequency and consistency, were not detected. Although variability in the RTT phenotype contributes to the dysbiosis of the gut microbiome, we presently cannot infer causality between gut bacterial dysbiosis and gastrointestinal dysfunction. Nevertheless, alterations in the gut metabolome may provide clues to the pathophysiology of gastrointestinal problems in RTT.
Sections du résumé
BACKGROUND
Gastrointestinal problems affect the health and quality of life of individuals with Rett syndrome (RTT) and pose a medical hardship for their caregivers. We hypothesized that the variability in the RTT phenotype contributes to the dysbiosis of the gut microbiome and metabolome in RTT, predisposing these individuals to gastrointestinal dysfunction.
OBJECTIVES
We characterized the gut bacterial microbiome and metabolome in girls and young women with RTT (n = 44) and unaffected controls (n = 21), and examined the relation between the composition of the microbiome and variations in the RTT phenotype.
METHODS
Demographics and clinical information, including growth and anthropometric measurements, pubertal status, symptoms, clinical severity score, bowel movement, medication use, and dietary intakes were collected from the participants. Fecal samples were collected for analysis of the gut microbiome using Illumina MiSeq-based next-generation sequencing of the 16S rRNA gene followed by bioinformatics analysis of microbial composition, diversity, and community structure. Selected end-products of microbial protein metabolism were characterized by liquid chromatography-mass spectrometry.
RESULTS
The gut bacterial microbiome differed within the RTT cohort based on pubertal status (p<0.02) and clinical severity scores (p<0.02) of the individuals and the type of diet (p<0.01) consumed. Although the composition of the gut microbiome did not differ between RTT and unaffected individuals, concentrations of protein end-products of the gut bacterial metabolome, including γ-aminobutyric acid (GABA) (p<0.001), tyrosine (p<0.02), and glutamate (p<0.06), were lower in the RTT cohort. Differences in the microbiome within RTT groups, based on symptomatic anxiety, hyperventilation, abdominal distention, or changes in stool frequency and consistency, were not detected.
CONCLUSIONS
Although variability in the RTT phenotype contributes to the dysbiosis of the gut microbiome, we presently cannot infer causality between gut bacterial dysbiosis and gastrointestinal dysfunction. Nevertheless, alterations in the gut metabolome may provide clues to the pathophysiology of gastrointestinal problems in RTT.
Identifiants
pubmed: 33956889
doi: 10.1371/journal.pone.0251231
pii: PONE-D-21-01185
pmc: PMC8101921
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0251231Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Pediatr Gastroenterol Nutr. 2021 Mar 1;72(3):354-360
pubmed: 32969958
J Med Genet. 2014 Mar;51(3):152-8
pubmed: 24399845
Aliment Pharmacol Ther. 2015 Aug;42(4):418-27
pubmed: 26104013
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
J Pediatr Gastroenterol Nutr. 2012 Sep;55(3):292-8
pubmed: 22331013
Cell Mol Gastroenterol Hepatol. 2016 Dec 11;3(2):218-230
pubmed: 28275689
Sci Adv. 2019 Feb 06;5(2):eaau8317
pubmed: 30775438
Microbiome. 2020 Apr 2;8(1):45
pubmed: 32238195
ISME J. 2011 Feb;5(2):169-72
pubmed: 20827291
Front Immunol. 2019 Mar 11;10:277
pubmed: 30915065
J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):323-9
pubmed: 26020482
Clin Microbiol Rev. 2007 Oct;20(4):593-621
pubmed: 17934076
Appl Environ Microbiol. 2013 Sep;79(17):5112-20
pubmed: 23793624
World J Gastroenterol. 2014 Feb 7;20(5):1192-210
pubmed: 24574795
J Pediatr Gastroenterol Nutr. 2019 Jun;68(6):799-805
pubmed: 30664568
Bioinformatics. 2010 Mar 15;26(6):715-21
pubmed: 20130030
Nutrients. 2017 May 01;9(5):
pubmed: 28468301
Cell Host Microbe. 2015 Oct 14;18(4):489-500
pubmed: 26468751
Gastroenterology. 2020 Jan;158(1):176-188.e7
pubmed: 31586453
Ann Neurol. 2010 Dec;68(6):944-50
pubmed: 21154482
Cell. 2012 Mar 16;148(6):1258-70
pubmed: 22424233
Neuroscience. 2016 Jun 2;324:131-9
pubmed: 26964681
Pediatr Infect Dis J. 2020 Sep;39(9):e226-e233
pubmed: 32453194
Neurology. 2008 Apr 15;70(16):1313-21
pubmed: 18337588
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Bioinformatics. 2010 Jun 1;26(11):1463-4
pubmed: 20395285
Gastroenterology. 2011 Nov;141(5):1792-801
pubmed: 21820992
Curr Opin Biotechnol. 2015 Apr;32:35-41
pubmed: 25448230
PLoS One. 2015 Oct 01;10(10):e0137725
pubmed: 26427004
Ann Gastroenterol. 2015 Apr-Jun;28(2):203-209
pubmed: 25830558
Brain Behav Immun. 2014 May;38:1-12
pubmed: 24370461
Microb Cell Fact. 2020 Jul 28;19(1):152
pubmed: 32723385
Cell Host Microbe. 2015 May 13;17(5):565-76
pubmed: 25974299
Nat Rev Microbiol. 2012 Nov;10(11):735-42
pubmed: 23000955
Ann Neurol. 2000 May;47(5):670-9
pubmed: 10805343
Nature. 2014 Jan 23;505(7484):559-63
pubmed: 24336217
Nutr Diabetes. 2014 Jun 30;4:e121
pubmed: 24979150
Front Microbiol. 2017 Nov 15;8:2224
pubmed: 29187837
Nature. 2012 May 09;486(7402):222-7
pubmed: 22699611
Gastroenterology. 2011 Nov;141(5):1782-91
pubmed: 21741921
Microbiome. 2016 Jul 30;4(1):41
pubmed: 27473171
Inflamm Bowel Dis. 2012 May;18(5):968-84
pubmed: 21936031
Scand J Gastroenterol. 2019 Aug;54(8):969-975
pubmed: 31329473
Curr Dev Disord Rep. 2016 Mar;3(1):75-81
pubmed: 27398286
Am J Clin Nutr. 2018 Jun 1;107(6):965-983
pubmed: 29757343
Science. 2011 Oct 7;334(6052):105-8
pubmed: 21885731
Br J Nutr. 1967 Aug;21(3):681-9
pubmed: 6052883
J Pediatr. 2006 Mar;148(3):347-52
pubmed: 16615965
Genome Med. 2017 Mar 29;9(1):32
pubmed: 28356137
Neurogastroenterol Motil. 2015 Aug;27(8):1156-61
pubmed: 26031318
Anaerobe. 2010 Aug;16(4):444-53
pubmed: 20603222
EBioMedicine. 2019 Aug;46:499-511
pubmed: 31327695
PLoS One. 2020 Jan 16;15(1):e0227967
pubmed: 31945114
Gastroenterology. 2017 Jan;152(1):111-123.e8
pubmed: 27725146
Int J Mol Sci. 2017 Feb 07;18(2):
pubmed: 28178201
Nat Rev Gastroenterol Hepatol. 2009 May;6(5):306-14
pubmed: 19404271
Clin Ther. 2015 May 1;37(5):976-83
pubmed: 26046240
Microbiome. 2014 Sep 30;2(1):30
pubmed: 27367037
Clin J Pain. 2013 Aug;29(8):744-6
pubmed: 23835769
Cell Host Microbe. 2014 Mar 12;15(3):382-392
pubmed: 24629344
J Transl Med. 2017 Apr 8;15(1):73
pubmed: 28388917
J Pediatr Gastroenterol Nutr. 2011 Nov;53(5):569-74
pubmed: 21637127
Sci Rep. 2020 Mar 6;10(1):4247
pubmed: 32144387
Neurology. 2012 Oct 16;79(16):1653-61
pubmed: 23035069
PLoS One. 2013 Jun 17;8(6):e66019
pubmed: 23799070
J Mol Diagn. 2019 May;21(3):449-461
pubmed: 31005411